What is NAGE's pharmaceuticals segment — marketing?

NAGE (NAGE) reported pharmaceuticals segment — marketing of $0 in Q1 2026.

What does pharmaceuticals segment — marketing mean?

Encompasses costs related to market research, product positioning, and sales support activities for the pharmaceutical segment. Unlike direct advertising, these costs often support the broader commercial infrastructure and strategic market development. It provides insight into the segment's efforts to maintain competitive positioning.

NAGE NAGE Pharmaceuticals segment — Marketing

Other segment segments

Consumer Products segment

$3.42M+39.5%

Ingredients segment

$96K+284%

Analytical Reference Standards and Services segment

$0—

Similar metrics at other companies

AMP

AMPHPharmaceutical Products — Marketing And Advertising Expense

$3.06M-21.3%

BLCOPharmaceuticals — Selling, general and administrative (Note 4)

$138M-9.8%

INCYReportable Segment — Sales and marketing

$259.56M+0.7%

BAXPharmaceuticals — Cost of Sales

$458M+15.7%

BAXPharmaceuticals — Selling, general and administrative expenses

$102M-1.0%

SGPReporting Segment — Marketing expense

$250.75K+389%

Other financials

Income statement

See full

Revenue$31.5M+3.3%

Gross profit$20.0M+3.3%

Operating income$1.6M-67.0%

Net income$6.3M+24.8%

EPS (diluted)$0.07+16.7%

Balance sheet

See full

Cash & equivalents$66.5M+19.7%

Total debt$2.6M-26.9%

Total equity$82.3M+48.8%

Total assets$114.3M+40.6%

Cash flow

See full

Operating cash flow-$1.2M-115%

Valuation

See full

Market cap$254.07M-74.9%

Enterprise value$190.09M-79.7%

P/E13.6×-43.5×

P/S2×-6.8×

Profitability

See full

Gross margin64.3%+1.8pp

Operating margin10%-2.2pp

Net margin14.3%+1.2pp

FCF margin-70.4%—

Returns & leverage

See full

Return on equity27.1%-6.4pp

Debt / equity0×0.0×

Current ratio4.6×+0.9×

Where this comes from

Reported directly by NAGE in its filing.

Tagged under the XBRL concept us-gaap:MarketingExpense.

The official record: NAGE’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about NAGE's pharmaceuticals segment — marketing.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NAGE's pharmaceuticals segment — marketing?: NAGE (NAGE) reported pharmaceuticals segment — marketing of $0 in Q1 2026.
What does pharmaceuticals segment — marketing mean?: Encompasses costs related to market research, product positioning, and sales support activities for the pharmaceutical segment. Unlike direct advertising, these costs often support the broader commercial infrastructure and strategic market development. It provides insight into the segment's efforts to maintain competitive positioning.